Atlas Trials

Ovarian Adenocarcinoma

13 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Ovarian Adenocarcinoma

RecordFirmDate
A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer (NCT05451849)TCR2 Therapeutics2022-06-21
A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα) (NCT05001282)Elucida Oncology2021-09-13
The Effects of Exercise on Distress, Quality of Life, and Biomarkers in Ovarian Cancer Survivors (NCT03641287)University of Washington2018-12-05
PDR001 Plus LAG525 for Patients With Advanced Solid and Hematologic Malignancies (NCT03365791)Novartis Pharmaceuticals2018-01-24
Paclitaxel and Bevacizumab With or Without Emactuzumab in Treating Patients With Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (NCT02923739)M.D. Anderson Cancer Center2017-05-05
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors (NCT02834013)National Cancer Institute (NCI)2017-01-30
Dose Escalation of Cisplatin Hyperthermic Intraperitoneal Chemotherapy After Surgery in Patients With Unresectable Stage IIIC Ovarian, Tube or Peritoneal Primary Adenocarcinoma (NCT02217956)Gustave Roussy, Cancer Campus, Grand Paris2011-06-01
YKL-40 in Serum Samples From Patients With Newly Diagnosed Stage III-IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer Receiving Chemotherapy (NCT00899093)Gynecologic Oncology Group2007-09-01

Track Ovarian Adenocarcinoma automatically

Every clearance here is in the API, with alerts when new ones post.